Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Mar 1;9(1):6.
doi: 10.1186/s40900-023-00410-z.

Adopting recommendations for implementing patient involvement in cancer research: a funder's approach

Affiliations

Adopting recommendations for implementing patient involvement in cancer research: a funder's approach

Alexandre B Costa Alencar et al. Res Involv Engagem. .

Abstract

Background: The role of patients in cancer research is undergoing a significant evolution as all stakeholders seek to enhance the level of direct patient involvement in the design and development of clinical trials. However, there are significant hurdles that patients, patient advocates, laboratory researchers, clinical investigators, and funding institutions must overcome to implement relevant patient involvement in all aspects of biomedical research. By using innovative grant funding models, philanthropic organizations can lead the field in overcoming these challenges. Rising Tide Foundation for Clinical Cancer Research (RTFCCR), a private philanthropy that funds academic research, has developed a novel approach for requiring and supporting partnerships among grantees and patients in designing and conducting research projects. This paper presents a reflective case study of efforts to advance the field of patient involvement in clinical research.

Methods: The decision to focus on patient involvement stems from an expressed focus area established by the RTFCCR board of directors. In conducting this work, RTFCCR partnered with Patvocates, a patient advocacy and engagement network, to create a set of guiding documents and resources aimed at public and private health research funders within various national, international, and therapeutic settings. This effort included a landscape assessment, interviews with experts, and an iterative development process.

Results: To date, RTFCCR has completed and disseminated three guiding documents, one for funders, one for grant applicants, and one for patient advocates. These resources have already generated three major ongoing initiatives at RTFCCR: (1) inclusion of these recommendations in the foundation's funding guidelines; patient input to prioritization of research focus areas; and in topic selection for calls for proposals; (2) direct involvement of patient experts in the grant review process; and (3) a commitment to support high impact clinical research projects in Low- and Middle-Income Countries. Moreover, the foundation has launched a partnership with the International Cancer Research Partnership, the global alliance of cancer research organizations.

Conclusion: By using its grantmaking function and developing standardized approaches for implementation of patient involvement, RTFCCR is seeking to advance patient-centric cancer clinical research. This approach will continue to develop as it is implemented and shared with partners throughout the world.

Keywords: Call for proposals; Clinical research; Focus areas; Funding guidelines; Grant making; Grant review process; Low- and middle-income countries; Patient directed trials; Patient involvement; Philanthropic funding.

Plain language summary

The Rising Tide Foundation for Clinical Cancer Research (RTFCCR), a private philanthropy that funds academic research, has developed a novel approach for requiring and supporting partnerships among grantees (scientists) and patients in designing and conducting research projects.The decision to focus on patient involvement stems from an expressed focus area established by the RTFCCR board of directors. In conducting this work, RTFCCR partnered with Patvocates, a patient advocacy and engagement network. Patvocates conducted a landscape assessment, interviews with experts, and their collective experience as patient advocates. This work generated a set of guiding documents and resources. These resources are to help public and private health research funders to better understand current challenges and support scientists and patients through their funding mechanisms. Three guiding documents, one for funders, one for grant applicants, and one for patient advocates are now available for download at the RTFCCR website: https://www.risingtide-foundation.org/clinical-cancer-research/patient-engagement#start Delivering a paradigm change involves not only the introduction of additional requirements and rules, but also enhanced education of patients and investigators. By using its grantmaking function and developing standardized approaches for implementation of patient involvement, RTFCCR is seeking to advance patient-centric cancer clinical research.Development and implementation of consistent policies and procedures for the integration of the patients’ view in the design and review of research proposals is needed for funders as well as for research institutes, both public and private.

PubMed Disclaimer

Conflict of interest statement

Richard Stephens is Co-Editor-in-Chief of this journal. He played no part in any editorial considerations or decisions for this paper. The other authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Patient Involvement in Research initiative
Fig. 2
Fig. 2
Changes made to the RTFCC funding based on the recommendations developed in this project

Similar articles

Cited by

References

    1. BMBF. United Against Cancer. Berlin: Bundesministerium für Bildung und Forschung. (2020). https://www.bmbf.de/SharedDocs/Downloads/en/210907-unite-against-cancer..... Accessed 14 Dec 2021.
    1. Geissler J, Ryll B, di Priolo SL, Uhlenhopp M. Improving patient engagement in medicines research and development: a practical roadmap. Ther Innov Regul Sci. 2017;51(5):612–619. doi: 10.1177/2168479017706405. - DOI - PubMed
    1. Boudes M, Robinson P, Bertelsen N, et al. What do stakeholders expect from patient engagement: are these expectations being met? Health Expect. 2018;21(6):1035–1045. doi: 10.1111/hex.12797. - DOI - PMC - PubMed
    1. Addario B, Geissler J, Horn MK, et al. Including the patient voice in the development and implementation of patient-reported outcomes in cancer clinical trials. Health Expect. 2019;23(1):41–51. doi: 10.1111/hex.12997. - DOI - PMC - PubMed
    1. Culture and Process Change as a Priority for Patient Engagement in Medicines Development https://link.springer.com/content/pdf/10.1177/2168479016659104.pdf. Accessed 14 Dec 2021. - PMC - PubMed

LinkOut - more resources